pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 323 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Preclinical
    CPD-100Li
    Pancreatic Cancer Cascade Prodrug Inc
  • Preclinical
    CR-002
    Solid Tumor Crescent Biopharma Operating Co LLC
  • Preclinical
    CRB-091
    Colorectal Cancer Cancer Research and Biotechnology AG
  • Preclinical
← prev
page 4 of 11
next →
131
Pain89
Neurology1
CRO-67
Pancreatic Cancer
Noxopharm Ltd
  • Preclinical
    CS-028
    Pancreatic Cancer Lumosa Therapeutics Co Ltd
  • Preclinical
    CT-1001
    Refractory Multiple Myeloma Cure Therapeutics Co Ltd
  • Preclinical
    CT-262
    Breast Cancer Cairn Therapeutics Inc
  • Preclinical
    CTB-1
    Osteosarcoma GTS Biotech LLC
  • Preclinical
    CTH-401
    Ovarian Cancer Cartherics Pty Ltd
  • Preclinical
    CXR-102
    Squamous Non-Small Cell Lung Carcinoma CorriXR Therapeutics Inc
  • Preclinical
    CYT-102
    Recurrent Glioblastoma Multiforme (GBM) Cytea Bio
  • Preclinical
    Culnexin Inhibitors
    Triple-Negative Breast Cancer (TNBC) Culnexin Therapeutics LLC
  • Preclinical
    DHA-dFdC
    Leukemia AIkido Labs Inc
  • Preclinical
    DMR-001
    Essential Thrombocythemia$DMRA Damora Therapeutics, Inc.
  • Preclinical
    DPH-008
    Prostate Cancer Disruptive Pharma AB
  • Preclinical
    DPH-00X
    Unspecified Cancer Disruptive Pharma AB
  • Preclinical
    DUET-101
    Bladder Cancer Duet Therapeutics Inc
  • Preclinical
    DisPATCH
    Solid Tumor RootPath Genomics Inc
  • Preclinical
    Drug to Inhibit MDM2 for Retinoblastoma
    Retinoblastoma Spectocular LLC
  • Preclinical
    Drugs for Oncology
    Pancreatic Ductal Adenocarcinoma SRI International
  • Preclinical
    EB-104
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$ESLA Estrella Immunopharma, Inc.
  • Preclinical
    EIR-1003
    Neovascular Glaucoma EIR Biopharma Inc
  • Preclinical
    EPS-401
    Non-Small Cell Lung Cancer Epsilogen Ltd
  • Preclinical
    ERNA-101
    Ovarian Cancer$ERNA Ernexa Therapeutics Inc.
  • Preclinical
    EX-501
    Unspecified Cancer Exinda Therapeutics LLC
  • Preclinical
    Engineered Virus
    Glioblastoma Multiforme (GBM) Kopra Bio Inc
  • Preclinical
    FID-021
    Unspecified Cancer Fulgent Pharma LLC
  • Preclinical
    FID-023
    Leukemia Fulgent Pharma LLC
  • Preclinical
    FID-025
    Brain Cancer Fulgent Pharma LLC
  • Preclinical
    FLAG-003
    Pediatric Diffuse Intrinsic Pontine Glioma Flag Therapeutics Inc